Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT00773838
Brief Title: Study of Vorinostat (MK0683), an Histone Deacetylase (HDAC) Inhibitor in Combination With Bortezomib in Patients With Relapsed or Refractory Multiple Myeloma (MK-0683-095)

First Submitted : October 14, 2008
First Submitted that Met QC Criteria : October 15, 2008
First Posted : October 16, 2008 (Estimate)

Results First Submitted : March 5, 2021
Results First Submitted that Met QC Criteria : March 5, 2021
Results First Posted : April 1, 2021

Last Update Submitted that Met QC Criteria : March 5, 2021
Last Update Posted : April 1, 2021